Additionally, we provide evidence of enhanced T-cell response in the brain of mice surviving long-term after tumor induction, specifically CD4+ and effector memory CD4+ T-cells, suggestive of long-term immunity against glioma. The gene discussed is CD4; the disease is neoplasm.